Skip to content

Study on the relationship between esophageal motility and esophageal mucosal flora in nonerosive gastroesophageal reflux disease

Study on the relationship between esophageal motility and esophageal mucosal flora in nonerosive gastroesophageal reflux disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073066
Enrollment
Unknown
Registered
2023-06-30
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonerosive reflux disease

Interventions

Normal esophageal motility group:None
Ineffective esophageal motility group:None
Healthy control group:None

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) 45 years = age = 60 years old; 2) approximately the same course of disease; 3) meeting the NERD diagnostic criteria: 1 having discomfort symptoms such as acid regurgitation and heartburn; 2) endoscopic negative; 3) pathological acid reflux; 4) no cardiac retardation or other primary or secondary esophageal motility disorders; 5) there is no serious defect of anti-reflux barrier, that is, gastroesophageal reflux disc grade (gastroesophagealflapvalve,GEFV) is I-III grade. 6) No diabetes, thyroid dysfunction or immune system related diseases or chronic diseases such as peptic ulcer, severe atrophic gastritis, liver cirrhosis, chronic pancreatitis; 7) No malignant tumors of digestive system or other systems; 8) patients who have not used antibiotics or probiotics in recent 3 months. 9) No proton pump inhibitors (protonpumpinhibitors,PPIs), H2 receptor antagonists, gastrointestinal prokinetic drugs; 10) patients who are not currently infected with helicobacterpylori,H.pylori; 11) women who are not currently pregnant or lactating; 12) no severe cardiopulmonary insufficiency; 13) no history of upper gastrointestinal surgery; 14) no history of mental illness, genetic or metabolic diseases. 15) voluntarily accept and abide by this research program, be able to tolerate relevant tests, and be able to complete the questionnaire independently under the guidance of the researcher. Inclusion criteria for healthy individuals: 1) 45 years old = age = 60 years old; 2) Good health condition; 3) Does not meet any diagnostic criteria for functional and organic diseases; 4) Patients who have not used antibiotics or probiotics in the past 3 months; 5) I haven't taken proton pump inhibitors (PPIs), H2 receptor antagonists, and Prokinetic agent in recent 8 weeks; 6) Patients who are currently not infected with Helicobacter pylori (H. pylori); 7) Female patients who are currently not pregnant or breastfeeding; 8) Voluntarily accept and comply with this research protocol, be able to tolerate relevant tests, and independently complete the survey questionnaire under the guidance of the researcher.

Exclusion criteria

Exclusion criteria: 1) Age > 60 years old or < 45 years old; 2) do not meet NERD diagnostic criteria; 3) have cardiac retardation or other primary or secondary esophageal motility disorders; 4) have severe anti-reflux barrier defect, i.e. GEFV grade IV; 5) have diabetes, thyroid dysfunction or immune system related diseases or chronic diseases such as peptic ulcer, severe atrophic gastritis, liver cirrhosis, chronic pancreatitis, etc. 6) patients with malignant tumors of the digestive system or other systems; 7) patients who have used antibiotics or probiotics in the past 3 months; 8) patients who have taken PPIs preparations, H2 receptor antagonists and gastrointestinal motility drugs in the past 8 weeks; 9) patients with H.pylori infection; 10) women who are currently pregnant or breastfeeding; 11) severe cardiopulmonary insufficiency; 12) history of upper gastrointestinal surgery. 13) History of mental illness, history of genetic or metabolic diseases; 14) unwilling to accept and comply with this study program, or unable to tolerate relevant tests, or unable to complete the questionnaire independently under the guidance of the researcher.

Design outcomes

Primary

MeasureTime frame
flora;Esophageal motility;

Secondary

MeasureTime frame
BMI;Gender;Age;

Countries

China

Contacts

Public ContactHe Suyu

Suining Central Hospital

hesuyu2009@163.com+86 180 0825 8565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026